An evaluation of an Advanced Symptom Management System to monitor and manage chemotherapy-related toxicity
Completed
- Conditions
- Colorectal, breast and lung cancerCancerColorectal cancer, breast cancer, lung cancer
- Registration Number
- ISRCTN67370244
- Lead Sponsor
- niversity of Stirling (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
1. A diagnosis of breast, lung or colorectal cancer
2. Commencing a new course of chemotherapy treatment (defined as those patients commencing a new chemotherapy regime irrespective of stage of disease or line of treatment)
3. Receiving out-patient chemotherapy
4. Aged 18 years or over
5. Written informed consent given
6. Able to read and write English
7. Deemed by members of the clinical team as being physically and psychologically fit to participate in the study
Exclusion Criteria
1. Patients who are unable to meet the above criteria
2. Patients who do not agree to give access to their case notes
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in chemotherapy toxicity as a result of use of the mobile phone system and supporting information technology (IT) infrastructure
- Secondary Outcome Measures
Name Time Method Symptom outcomes that will be used for future statistical power calculations